1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Cierpicki, T.
Otlewski, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
302
1179
10.1006/JMBI.2000.4116
11183783
Determination of a High Precision Structure of a Novel Protein, Linum Usitatissimum Trypsin Inhibitor (Luti), Using Computer-Aided Assignment of Noesy Cross-Peaks
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7651.771
LINUM USITATISSINUM TRYPSIN INHIBITOR
1
nat
polymer
LUTI
no
yes
(ACE)SRRCPGKNAWPELVGKSGNMAAATVERENRNVHAIVLKEGSAMTKDFRCDRVWVIVNDHGVVTSVPHIT
XSRRCPGKNAWPELVGKSGNMAAATVERENRNVHAIVLKEGSAMTKDFRCDRVWVIVNDHGVVTSVPHIT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
FLAX
sample
4006
SEED
LINUM USITATISSIMUM
repository
Initial release
Version format compliance
Version format compliance
1
0
1999-12-17
1
1
2011-05-07
1
2
2011-07-13
HELIX
DETERMINATION METHOD: AUTHOR PROVIDED.
SHEET
DETERMINATION METHOD: AUTHOR PROVIDED.
PDBE
Y
PDBE
1999-12-08
REL
THE STRUCTURE WAS DETERMINED BASING ON 1760 EXPERIMENTAL RESTRAINTS DERIVED FROM TWO DIMENSIONAL 1H NMR EXPERIMENTS. NOESY CROSSPEAKS WERE ASSIGNED AUTOMATICALY USING NOAH/DYANA PROGRAM. STRUCTURE REFINEMENT WAS ACCOMPLISHED IN CNS.
LEAST RESTRAINT VIOLATION AND LOWEST ENERGY
40
20
NOESY
TOCSY
DQF-COSY
1H-15N HSQC
4.3
pH
293
K
simulated annealing
10% H2O/90% D2O
BRUNGER
refinement
CNS
0.9
structure solution
NMRPIPE
structure solution
SPARKY
structure solution
DYANA
structure solution
CNS
500
Varian
UNITYPLUS
ACE
0
n
1
ACE
0
A
SER
1
n
2
SER
1
A
ARG
2
n
3
ARG
2
A
ARG
3
n
4
ARG
3
A
CYS
4
n
5
CYS
4
A
PRO
5
n
6
PRO
5
A
GLY
6
n
7
GLY
6
A
LYS
7
n
8
LYS
7
A
ASN
8
n
9
ASN
8
A
ALA
9
n
10
ALA
9
A
TRP
10
n
11
TRP
10
A
PRO
11
n
12
PRO
11
A
GLU
12
n
13
GLU
12
A
LEU
13
n
14
LEU
13
A
VAL
14
n
15
VAL
14
A
GLY
15
n
16
GLY
15
A
LYS
16
n
17
LYS
16
A
SER
17
n
18
SER
17
A
GLY
18
n
19
GLY
18
A
ASN
19
n
20
ASN
19
A
MET
20
n
21
MET
20
A
ALA
21
n
22
ALA
21
A
ALA
22
n
23
ALA
22
A
ALA
23
n
24
ALA
23
A
THR
24
n
25
THR
24
A
VAL
25
n
26
VAL
25
A
GLU
26
n
27
GLU
26
A
ARG
27
n
28
ARG
27
A
GLU
28
n
29
GLU
28
A
ASN
29
n
30
ASN
29
A
ARG
30
n
31
ARG
30
A
ASN
31
n
32
ASN
31
A
VAL
32
n
33
VAL
32
A
HIS
33
n
34
HIS
33
A
ALA
34
n
35
ALA
34
A
ILE
35
n
36
ILE
35
A
VAL
36
n
37
VAL
36
A
LEU
37
n
38
LEU
37
A
LYS
38
n
39
LYS
38
A
GLU
39
n
40
GLU
39
A
GLY
40
n
41
GLY
40
A
SER
41
n
42
SER
41
A
ALA
42
n
43
ALA
42
A
MET
43
n
44
MET
43
A
THR
44
n
45
THR
44
A
LYS
45
n
46
LYS
45
A
ASP
46
n
47
ASP
46
A
PHE
47
n
48
PHE
47
A
ARG
48
n
49
ARG
48
A
CYS
49
n
50
CYS
49
A
ASP
50
n
51
ASP
50
A
ARG
51
n
52
ARG
51
A
VAL
52
n
53
VAL
52
A
TRP
53
n
54
TRP
53
A
VAL
54
n
55
VAL
54
A
ILE
55
n
56
ILE
55
A
VAL
56
n
57
VAL
56
A
ASN
57
n
58
ASN
57
A
ASP
58
n
59
ASP
58
A
HIS
59
n
60
HIS
59
A
GLY
60
n
61
GLY
60
A
VAL
61
n
62
VAL
61
A
VAL
62
n
63
VAL
62
A
THR
63
n
64
THR
63
A
SER
64
n
65
SER
64
A
VAL
65
n
66
VAL
65
A
PRO
66
n
67
PRO
66
A
HIS
67
n
68
HIS
67
A
ILE
68
n
69
ILE
68
A
THR
69
n
70
THR
69
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
HG1
MET
THR
20
24
1.57
4
A
A
O
HD1
VAL
HIS
65
67
1.45
10
A
A
O
HD1
VAL
HIS
65
67
1.58
19
A
A
O
HD1
VAL
HIS
65
67
1.47
1
A
ARG
2
-152.67
70.91
1
A
ARG
3
-151.12
88.91
1
A
ALA
42
-66.86
81.85
1
A
ASP
46
-52.04
171.95
1
A
ILE
68
-39.34
106.31
2
A
ARG
3
-151.35
89.23
2
A
TRP
10
-111.40
74.93
2
A
ASP
46
-47.25
161.12
2
A
ILE
68
-47.51
109.34
3
A
ARG
2
58.87
80.11
3
A
ARG
3
-174.42
98.13
3
A
TRP
10
-113.39
67.46
3
A
PRO
66
-58.86
97.49
4
A
ARG
2
-156.96
72.62
4
A
ARG
3
-101.52
74.36
4
A
PRO
5
-69.56
63.46
4
A
LYS
7
-33.23
143.52
4
A
TRP
10
-108.79
74.81
4
A
SER
41
-68.09
-178.09
4
A
ASP
46
-45.95
159.36
5
A
ARG
2
-103.22
52.50
5
A
ARG
3
-153.68
84.24
5
A
TRP
10
-109.52
74.36
5
A
ARG
30
-63.70
1.88
5
A
PRO
66
-60.32
99.84
6
A
ARG
2
-154.94
73.77
6
A
PRO
5
-63.23
-176.83
6
A
TRP
10
-116.71
67.35
6
A
ASN
29
-119.44
78.18
6
A
ALA
42
-62.54
81.14
6
A
ASP
46
-37.74
152.65
6
A
PRO
66
-56.92
98.32
7
A
TRP
10
-113.52
74.88
7
A
SER
41
-65.73
-173.93
7
A
ASP
46
-45.52
155.00
7
A
ILE
68
-44.11
103.54
8
A
ARG
2
-158.38
75.30
8
A
ARG
3
-174.40
94.83
8
A
TRP
10
-119.49
74.16
8
A
ARG
30
-64.62
1.88
8
A
SER
41
-66.01
-174.24
8
A
PRO
66
-58.06
103.39
8
A
ILE
68
-41.81
107.40
9
A
ARG
2
-154.69
61.84
9
A
SER
41
-72.76
-164.23
10
A
ARG
2
-159.47
77.87
10
A
ARG
3
46.82
83.28
10
A
TRP
10
-108.65
74.14
10
A
SER
41
-68.69
-166.09
10
A
ILE
68
-38.28
116.43
11
A
ARG
2
-113.85
59.28
11
A
ARG
3
53.73
81.31
11
A
ASN
29
-118.73
79.48
11
A
SER
41
-70.46
-162.38
11
A
ILE
68
-36.63
116.52
12
A
ARG
2
-155.58
64.14
12
A
PRO
5
-66.81
62.57
12
A
TRP
10
-108.00
73.95
12
A
PRO
66
-59.42
99.04
13
A
ARG
2
51.21
78.50
13
A
ARG
3
-164.79
105.24
13
A
TRP
10
-110.86
73.11
13
A
SER
41
-66.44
-167.72
13
A
ASP
46
-46.48
159.56
13
A
PRO
66
-54.47
95.46
13
A
ILE
68
-44.23
109.39
14
A
ARG
2
-168.20
68.16
14
A
TRP
10
-114.82
70.06
14
A
SER
41
-61.43
-178.00
14
A
PRO
66
-59.05
100.30
14
A
ILE
68
-47.71
109.92
15
A
ARG
2
-106.69
60.86
15
A
ARG
3
53.28
97.57
15
A
TRP
10
-119.45
72.13
15
A
SER
41
-67.61
-167.68
16
A
ARG
3
-161.54
98.99
16
A
TRP
10
-115.48
72.85
16
A
GLU
39
-56.64
107.92
16
A
ASP
46
-41.88
163.34
16
A
PRO
66
-60.81
90.82
17
A
ARG
2
51.64
81.90
17
A
ARG
3
-167.19
94.17
17
A
TRP
10
-112.62
69.89
17
A
SER
41
-68.27
-166.58
18
A
ARG
2
57.97
78.16
18
A
ARG
3
-160.99
67.63
18
A
TRP
10
-110.34
68.93
18
A
ARG
30
-62.58
0.97
18
A
SER
41
-67.62
-176.01
18
A
PRO
66
-65.69
89.29
19
A
ARG
2
-160.46
84.66
19
A
ARG
3
-154.01
77.34
19
A
TRP
10
-112.52
73.48
19
A
SER
41
-67.62
-179.32
19
A
ASP
46
-44.81
160.84
19
A
PRO
66
-57.75
92.17
20
A
ARG
3
55.77
90.65
20
A
TRP
10
-119.73
68.15
20
A
SER
41
-69.71
-177.22
20
A
PRO
66
-57.91
99.86
LINUM USITATISSINUM TRYPSIN INHIBITOR
Solution structure of Linum usitatissinum trypsin inhibitor (LUTI)
1
N
N
A
TRP
10
A
TRP
11
HELX_P
A
LEU
13
A
LEU
14
5
H1
4
A
GLY
18
A
GLY
19
HELX_P
A
GLU
28
A
GLU
29
1
H2
11
disulf
2.031
A
CYS
4
A
SG
CYS
5
1_555
A
CYS
49
A
SG
CYS
50
1_555
covale
1.332
A
ACE
0
A
C
ACE
1
1_555
A
SER
1
A
N
SER
2
1_555
SERINE PROTEINASE INHIBITOR
SERINE PROTEINASE INHIBITOR, TRYPSIN INHIBITOR
1DWM
PDB
1
1DWM
0
69
1DWM
0
69
1DWM
A
1
1
70
1
1
A
HIS
33
A
HIS
34
A
LYS
38
A
LYS
39
A
ARG
51
A
ARG
52
A
VAL
56
A
VAL
57
1
P 1